Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $2.45 million. The enterprise value is -$866,088.
Market Cap | 2.45M |
Enterprise Value | -866,088 |
Important Dates
The next estimated earnings date is Monday, November 11, 2024, after market close.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SLRX has 1.44 million shares outstanding. The number of shares has increased by 69.10% in one year.
Shares Outstanding | 1.44M |
Shares Change (YoY) | +69.10% |
Shares Change (QoQ) | +14.51% |
Owned by Insiders (%) | 2.52% |
Owned by Institutions (%) | 2.15% |
Float | 1.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.45 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.98
Current Ratio | 2.98 |
Quick Ratio | 2.78 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -119.83% and return on invested capital (ROIC) is -78.11%.
Return on Equity (ROE) | -119.83% |
Return on Assets (ROA) | -53.99% |
Return on Capital (ROIC) | -78.11% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.23M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.09% in the last 52 weeks. The beta is 0.96, so SLRX's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | -73.09% |
50-Day Moving Average | 1.62 |
200-Day Moving Average | 3.19 |
Relative Strength Index (RSI) | 51.44 |
Average Volume (20 Days) | 937,170 |
Short Selling Information
The latest short interest is 1,528, so 0.11% of the outstanding shares have been sold short.
Short Interest | 1,528 |
Short Previous Month | 15,020 |
Short % of Shares Out | 0.11% |
Short % of Float | 0.11% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.74M |
Pretax Income | -6.46M |
Net Income | -6.46M |
EBITDA | -6.73M |
EBIT | -6.74M |
Earnings Per Share (EPS) | -$12.42 |
Balance Sheet
Cash & Cash Equivalents | 3.27M |
Total Debt | n/a |
Net Cash | 3.27M |
Net Cash Per Share | $2.27 |
Equity (Book Value) | 2.38M |
Book Value Per Share | 3.70 |
Working Capital | 2.34M |
Cash Flow
Operating Cash Flow | -7.69M |
Capital Expenditures | n/a |
Free Cash Flow | -7.69M |
FCF Per Share | -$5.33 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SLRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -69.10% |
Shareholder Yield | -69.10% |
Earnings Yield | -268.59% |
FCF Yield | -319.37% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 0.125:1.
Last Split Date | Jun 17, 2024 |
Split Type | Reverse |
Split Ratio | 0.125:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |